Thai regulator approves AstraZeneca vaccine for emergency use

BANGKOK (Reuters): Thailand's Food and Drug Administration (FDA) has granted emergency use approval for the Covid-19 vaccine of AstraZeneca, three health ministry sources said on Thursday (Jan 21).

Thailand is set to import 200,000 doses of the AstraZeneca vaccine, with the first 50,000 doses expected to arrive next month, Health Minister Anutin Charnvirakul said on Wednesday.

The three senior ministry sources, who requested anonymity because they were not authorised to speak to media, said the regulator had approved the AstraZeneca vaccine on Wednesday, applicable for a period of one year.

One of the sources said approval applied only to doses manufactured overseas.

Thailand has signed a deal with AstraZeneca to produce 26 million doses of its vaccine locally through the firm Siam Bioscience.

Thailand's FDA has so far received registration requests for vaccines from AstraZeneca and China's Sinovac Biotech.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Thailand , Astrazeneca , approve , vaccine


Did you find this article insightful?


100% readers found this article insightful

Next In Aseanplus News

Asean News Headlines as at 7pm on Thursday (March 4)
Moody’s bullish on Philippines and Asean nations
UN tells Myanmar military to 'stop murdering' protesters
Vaccine passport, lower marriage age on table at China's political advisory meeting
Amendments to Philippine anti-drug law erode presumption of innocence: Lawmakers
Indonesia's factory activity slows in February
Philippine journalist Ressa takes stand to rebut govt tax evasion lawsuits
Hong Kong man makes death-defying leap from eighth-floor flat to an adjacent rooftop after fire breaks out in his building
Facebook bans accounts linked to Thai military operations in deep South
Vietnam's youngest heart transplant patient leaves hospital

Stories You'll Enjoy